Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 7, 2025Oct 7 5:51 PMGuyer William
Proposed Sale
20,000$89.85$1.8M—

View →

Oct 1, 2025Oct 1 7:34 PMBELANOFF JOSEPH K
Proposed Sale
40,000$83.11$3.3M—

View →

Oct 1, 2025Oct 1 5:54 PMMaduck Sean
Proposed Sale
20,000$83.11$1.7M—

View →

Oct 1, 2025Oct 1 5:42 PMLyon Joseph Douglas
Proposed Sale
5,000$83.11$415.6K—

View →

Sep 10, 2025Sep 10 1:50 PMSwisher Daniel N JR
Proposed Sale
2,200$72.45$159.4K—

View →

Sep 2, 2025Sep 2 8:31 PMGuyer William
Proposed Sale
20,000$69.72$1.4M—

View →

Sep 2, 2025Sep 2 8:23 PMMaduck Sean
Proposed Sale
20,000$69.72$1.4M—

View →

Sep 2, 2025Sep 2 8:16 PMLyon Joseph Douglas
Proposed Sale
5,000$69.72$348.6K—

View →

Sep 2, 2025Sep 2 8:09 PMBELANOFF JOSEPH K
Proposed Sale
40,000$69.72$2.8M—

View →

Aug 22, 2025Aug 22 2:58 PMRobb Gary Charles
Proposed Sale
2,326$71.27$165.8K—

View →

Aug 11, 2025Aug 11 2:20 PMSwisher Daniel N JR
Proposed Sale
2,200$72.30$159.1K—

View →

Aug 5, 2025Aug 5 5:05 PMGuyer William
Proposed Sale
20,000$71.77$1.4M—

View →

Aug 1, 2025Aug 1 3:25 PMLyon Joseph Douglas
Proposed Sale
5,000$67.17$335.9K—

View →

Aug 1, 2025Aug 1 3:11 PMMaduck Sean
Proposed Sale
20,000$67.15$1.3M—

View →

Aug 1, 2025Aug 1 3:00 PMBELANOFF JOSEPH K
Proposed Sale
615$67.17$41.3K—

View →

Jul 17, 2025Jul 17 8:00 PMBELANOFF JOSEPH K
Proposed Sale
40,000$72.85$2.9M—

View →

Jul 10, 2025Jul 10 4:21 PMSwisher Daniel N JR
Proposed Sale
2,200$71.08$156.4K—

View →

Jul 1, 2025Jul 1 6:09 PMMaduck Sean
Proposed Sale
20,000$73.40$1.5M—

View →

Jul 1, 2025Jul 1 6:01 PMLyon Joseph Douglas
Proposed Sale
5,000$73.40$367.0K—

View →

Jul 1, 2025Jul 1 5:52 PMGuyer William
Proposed Sale
20,000$73.40$1.5M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 2, 2026Oct 5 11:58 PMRoberto Wandenkolk VieiraPresident, Oncology
Option Exercise
8,333$21.63133,334(D)

View →

Oct 2, 2026Oct 5 11:54 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
9,190$19.2644,167(D)

View →

Oct 1, 2026Oct 5 11:54 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
810$13.563,357(D)

View →

Oct 2, 2026Oct 5 11:49 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
24,587$8.2741,986(D)

View →

Oct 1, 2026Oct 5 11:49 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
413$8.2766,573(D)

View →

Oct 1, 2026Oct 5 11:44 PMJustin Frederick GunnPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Grant/Award
100,000$114.03100,000(D)

View →

Sep 17, 2026Sep 18 11:47 PMGary Charles RobbChief Business Officer
Option Exercise
17,493$8.27182,507(D)

View →

Sep 14, 2026Sep 16 8:30 PMJoseph Douglas LyonChief Accounting & Technology Officer
Option Exercise
10,000$13.564,167(D)

View →

Sep 1, 2026Sep 4 1:16 AMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.2766,986(D)

View →

Sep 2, 2026Sep 4 1:02 AMRoberto Wandenkolk VieiraPresident, Oncology
Option Exercise
58,333$21.63141,667(D)

View →

Aug 26, 2026Aug 28 8:30 PMKimberly ParkDirector
Option Exercise
30,000$13.4930,000(D)

View →

Aug 25, 2026Aug 27 8:30 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
30,955$11.35169,045(D)

View →

Aug 14, 2026Aug 18 8:30 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
3,664$8.2791,986(D)

View →

Aug 10, 2026Aug 12 8:27 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
1,031$8.2795,650(D)

View →

Aug 10, 2026Aug 12 8:26 PMWilliam GuyerChief Development Officer
Option Exercise
16,300$21.65110,000(D)

View →

Aug 4, 2026Aug 6 10:44 PMWilliam GuyerChief Development Officer
Option Exercise
3,700$21.65126,300(D)

View →

Aug 3, 2026Aug 5 9:51 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
20,305$8.2796,681(D)

View →

Jul 30, 2026Aug 3 8:30 PMAtabak MokariChief Financial Officer
Option Exercise
80,000$23.0695,833(D)

View →

Jul 15, 2026Jul 17 10:31 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$23.06175,833(D)

View →

Jul 7, 2026Jul 8 11:54 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65130,000(D)

View →

Page 1 of 3

Next →